Epilepsy treatment starts with medication and works for about two-thirds of people. For the remaining third, options include surgery, implanted devices, dietary therapy, and newer treatments like pharmaceutical-grade CBD. The right approach depends on your seizure type, how well you respond to initial drugs, and whether your seizures originate from one specific area of the brain.
Medication Is the First Step
Anti-seizure medications are the foundation of epilepsy treatment, and the specific drug your doctor chooses depends heavily on the type of seizures you have. This matters because a medication that controls one seizure type can sometimes worsen another.
For focal seizures, which start in one area of the brain, carbamazepine, oxcarbazepine, and lamotrigine are the standard first choices. For generalized tonic-clonic seizures (the kind most people picture when they think of epilepsy, involving full-body stiffening and shaking), valproate is the go-to option. If valproate isn’t suitable, perhaps due to side effects or pregnancy planning, lamotrigine, levetiracetam, zonisamide, and topiramate are alternatives.
Absence seizures, which cause brief staring spells, respond best to ethosuximide or valproate. Myoclonic seizures, involving sudden muscle jerks, are also treated primarily with valproate, with levetiracetam as an alternative. These medications work through different biological pathways. Some calm overactive brain cells by regulating how sodium or calcium moves through nerve cell walls. Others boost the brain’s natural braking system, a chemical called GABA that quiets neural firing. Levetiracetam works through a distinct mechanism involving proteins on the surface of nerve cell vesicles, which is partly why it’s useful when other drugs fail.
Most people start on a single medication at a low dose, which is gradually increased until seizures stop or side effects become limiting. If the first drug doesn’t work, switching to a different single medication is typically tried before combining two drugs together.
When Medications Stop Working
If seizures continue despite adequate trials of two appropriately chosen medications, either alone or in combination, epilepsy is classified as drug-resistant. The International League Against Epilepsy uses this two-drug threshold as the formal definition. At that point, the odds that a third or fourth medication will achieve full seizure control drop significantly, and it’s time to explore other options.
Referral to a specialized epilepsy center is the recommended next step. These centers perform advanced testing, including prolonged video-EEG monitoring and brain imaging, to confirm the diagnosis, pinpoint where seizures originate, and determine whether surgery or other treatments are viable. The most important question at this stage is whether surgery could help, because it’s the only treatment with the potential to cure epilepsy outright.
Surgery for Drug-Resistant Epilepsy
Epilepsy surgery involves removing or disconnecting the brain tissue where seizures start. It works best when seizures clearly originate from a single identifiable area, particularly in the temporal lobe. Success rates for temporal lobe surgery are 60 to 80 percent for long-term seizure freedom. For seizures originating outside the temporal lobe, success rates are lower but still meaningful, ranging from 40 to 60 percent.
Not everyone is a candidate. The seizure focus has to be located in an area that can be removed without causing unacceptable problems with language, movement, or memory. Having a visible structural abnormality on brain imaging and consistent electrical findings on EEG are strong predictors of a good outcome. When at least one of these favorable factors is present, the seizure freedom rate after surgery climbs to about 58 percent even in repeat operations. For people who meet the criteria, surgery remains one of the most effective treatments available for drug-resistant epilepsy, yet it’s consistently underused.
Implanted Devices
For people who aren’t surgical candidates or whose seizures persist after surgery, implanted neuromodulation devices offer another layer of treatment. Three main types are currently available, and they work in fundamentally different ways.
Vagus Nerve Stimulation (VNS)
A small generator implanted in the chest sends regular electrical pulses to the vagus nerve in the neck. These signals travel up to the brainstem and increase levels of norepinephrine throughout the brain, which helps suppress seizure activity. Results improve over time. In the initial clinical trials, seizure reduction was modest (roughly 25 percent over the short term), but long-term data show median seizure reductions of 56 percent after about five years and up to 66 percent at three years in some large studies. VNS is the oldest and most widely used of the three devices.
Responsive Neurostimulation (RNS)
This device is implanted directly in the skull and continuously monitors brain electrical activity at the seizure focus. When it detects the start of a seizure, it delivers a brief electrical pulse to disrupt the abnormal activity before it spreads. Think of it as a defibrillator for the brain. Long-term seizure reduction is roughly 44 percent at one year and improves to 53 percent at two years, with the manufacturer reporting 73 percent median reduction by year eight. The latest models have battery lives of up to about eight years under typical settings. RNS is particularly useful when seizures come from areas of the brain that can’t be safely removed.
Deep Brain Stimulation (DBS)
Electrodes are placed in a deep brain structure called the anterior nucleus of the thalamus, which acts as a relay station for seizure circuits. Like VNS, DBS delivers scheduled stimulation rather than reacting to seizures in real time. It’s approved for focal epilepsy that hasn’t responded to three or more medications.
All three devices are add-on treatments. They rarely eliminate seizures entirely but can meaningfully reduce their frequency and severity, often improving quality of life even when seizure freedom isn’t achieved.
Dietary Therapy
The ketogenic diet has been used to treat epilepsy since the 1920s, and it remains one of the most effective non-drug options, especially for children with drug-resistant seizures. The classic version gets about 90 percent of its calories from fat, 6 percent from protein, and just 4 percent from carbohydrates (a 4:1 ratio of fat to everything else). This forces the brain to burn fat-derived ketones instead of glucose, which appears to stabilize neural activity through several mechanisms that researchers are still working to fully understand.
The strictness of the classic diet makes it hard to maintain, so several modified versions exist. The Modified Atkins Diet is less restrictive, at roughly 77 percent fat and 6 percent carbohydrate, and studies report seizure freedom in about 10 percent of patients with significant reductions in many others. The Low Glycemic Index Treatment is the most flexible option, at 60 percent fat and 12 percent carbohydrate, and achieves 50 percent or greater seizure reduction in many patients. A medium-chain triglyceride version uses a specific type of fat that produces ketones more efficiently, allowing slightly more protein and carbohydrate in the diet.
These diets require medical supervision. They’re not something to try on your own. A dietitian experienced in epilepsy management typically designs and monitors the plan, and regular blood work is needed to check cholesterol, kidney function, and nutritional status. Most people who respond to dietary therapy see results within the first few months.
CBD-Based Treatment
Pharmaceutical-grade cannabidiol (sold as Epidiolex) is approved in the United States for seizures associated with three specific conditions: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex, in patients one year of age and older. This is not the same as over-the-counter CBD oil. Epidiolex is a highly purified, plant-derived formulation with consistent dosing and quality control.
Clinical trials established efficacy at doses between 10 and 25 mg/kg/day, with treatment typically starting low and increasing gradually to improve tolerability. The maximum recommended maintenance dose is 20 mg/kg/day for Lennox-Gastaut and Dravet syndromes and 25 mg/kg/day for tuberous sclerosis complex. It’s used alongside other seizure medications, not as a standalone treatment. Liver function monitoring is recommended, particularly when it’s taken with valproate.
Rescue Medications for Seizure Clusters
Some people with epilepsy experience clusters of seizures, multiple seizures occurring close together over hours or days. Rescue medications are prescribed in advance so that you or a caregiver can administer them at home to break the cluster before it escalates. Diazepam nasal spray is one common option. If a second dose is needed, it should be given at least four hours after the first, and no more than two doses should be used for a single episode. There are also limits on frequency: no more than one episode treated every five days, and no more than five episodes per month. Midazolam nasal spray is another rescue option with a similar role.
Having a clear seizure action plan, one that specifies when to use rescue medication, when to call for emergency help, and what information to give paramedics, makes a real difference during these situations.
Managing Triggers and Daily Life
Medication and procedures are only part of the picture. Day-to-day habits play a real role in seizure frequency. Sleep deprivation is one of the most reliable seizure triggers, so consistently getting seven to eight hours of sleep matters more for people with epilepsy than for the general population. Alcohol, even in moderate amounts, can lower the seizure threshold, and the withdrawal period after heavy drinking is particularly risky.
Tracking your seizures in a diary or app helps identify personal patterns and triggers. Some people notice that stress, illness, missed meals, or specific times in the menstrual cycle are associated with increased seizure activity. Once you identify a pattern, you can take targeted steps to reduce risk during those periods, whether that means prioritizing sleep before a stressful week or adjusting medication timing with your doctor’s guidance.
Regular exercise is safe for most people with epilepsy and may help reduce seizure frequency, in addition to its benefits for mood and overall health. Tobacco and recreational drugs can interfere with seizure medications or lower the seizure threshold directly. Even some over-the-counter supplements and medications can interact with anti-seizure drugs, so checking with your prescriber before adding anything new is a practical habit worth maintaining.
Depression and anxiety are significantly more common in people with epilepsy than in the general population, and untreated mental health conditions can worsen seizure control. Stress-reduction techniques, maintaining social connections, and seeking help for emotional difficulties aren’t just feel-good advice. They’re part of effective epilepsy management.